Cited by 669Virus-based gene therapy researchImmunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 Research

The DOI matches its Crossref record; 132 of the 134 references it cites were found in a registry or an index.

Adenoviruses as vaccine vectors

Open access

Tatsis, Nia, Ertl, Hildegund C.J.·2004·Molecular Therapy

DOI 10.1016/j.ymthe.2004.07.013PMC PMC7106330

Open this paper in CoChat — free account

Abstract

Adenoviruses have transitioned from tools for gene replacement therapy to bona fide vaccine delivery vehicles. They are attractive vaccine vectors as they induce both innate and adaptive immune responses in mammalian hosts. Currently, adenovirus vectors are being tested as subunit vaccine systems for numerous infectious agents ranging from malaria to HIV-1. Additionally, they are being explored as vaccines against a multitude of tumor-associated antigens. In this review we describe the molecular biology of adenoviruses as well as ways the adenovirus vectors can be manipulated to enhance their efficacy as vaccine carriers. We describe methods of evaluating immune responses to transgene products expressed by adenoviral vectors and discuss data on adenoviral vaccines to a selected number of pathogens. Last, we comment on the limitations of using human adenoviral vectors and provide alternatives to circumvent these problems. This field is growing at an exciting and rapid pace, thus we have limited our scope to the use of adenoviral vectors as vaccines against viral pathogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2004.07.013

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“3 , are now available [61] [62] [63] [64] .”
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,589
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
Yang, Y., Li, Q., Ertl, H. C. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,033
Self-citation
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 793
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655

Flagged first, then by citations

Show all 134 references

2 of the 134 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Fisher, 2000, Protection and retargeting of adenovirus using a multifunctional hydrophilic polymer, Mol. Ther., 1S, 57

Sorted by citations

Items 101–200 of 665

Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran
Babamahmoodi, F., Saeedi, M., Alizadeh‐Navaei, R., Hedayatizadeh‐Omran, A., Mousavi, S. A., Ovaise, G., Kordi, S., Akbari, Z., Azordeh, M., Ahangarkani, F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00963-7 · Cited by 79
From the first to the third generation adenoviral vector: What parameters are governing the production yield?
Dormond, E., Perrier, M., & Kamen, A. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.10.003 · Cited by 70
Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization
Xing, Z., & Lichty, B. D. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.01.017 · Cited by 70
CRISPR/Cas9-mediated genome editing in nonhuman primates
Kang, Y., Chu, C., Wang, F., & Niu, Y. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039982 · Cited by 69
Dry-Coated Live Viral Vector Vaccines Delivered by Nanopatch Microprojections Retain Long-Term Thermostability and Induce Transgene-Specific T Cell Responses in Mice
Pearson, F. E., McNeilly, C. L., Crichton, M. L., Primiero, C., Yukiko, S. R., Fernando, G. J. P., Chen, X., Gilbert, S. C., Hill, A. V. S., & Kendall, M. A. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067888 · Cited by 68
Single Intranasal Immunization with Recombinant Adenovirus-Based Vaccine Induces Protective Immunity against Respiratory Syncytial Virus Infection
Yu, J., Kim, S., Lee, J.-B., & Chang, J. (2007) · Journal of Virology · doi:10.1128/jvi.02372-07 · Cited by 68
Vaccination with Recombinant Adenoviruses Expressing the Peste des Petits Ruminants Virus F or H Proteins Overcomes Viral Immunosuppression and Induces Protective Immunity against PPRV Challenge in Sheep
Rojas, J. M., Moreno, H., Sancho, F. V., Peña, L., Sevilla, N., & Martı́n, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101226 · Cited by 68
Towards purification of adenoviral vectors based on membrane technology
Peixoto, C., Ferreira, T. B., Sousa, M. F. Q., Carrondo, M. J. T., & Alves, P. M. (2008) · Biotechnology Progress · doi:10.1002/btpr.25 · Cited by 67
Murine Airway Luminal Antituberculosis Memory CD8 T Cells by Mucosal Immunization Are Maintained Via Antigen-Driven In Situ Proliferation, Independent of Peripheral T Cell Recruitment
Jeyanathan, M., Mu, J., McCormick, S. M., Damjanovic, D., Small, C.-L. N., Shaler, C. R., Kugathasan, K., & Xing, Z. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200910-1583oc · Cited by 66
A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge
Zhou, D., Wu, T.-L., Lasaro, M. O., Latimer, B. P., Parzych, E. M., Bian, A., Li, Y., Li, H., Erikson, J., Xiang, Z., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.202 · Cited by 66
Self-citation
Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling
Waickman, A. T., Victor, K., Li, T., Hatch, K., Rutvisuttinunt, W., Medin, C. L., Gabriel, B., Jarman, R. G., Friberg, H., & Currier, J. R. (2019) · Nature Communications · doi:10.1038/s41467-019-11634-7 · Cited by 67
Construction and application of adenoviral vectors
Zhang, H., Wang, H., An, Y., & Chen, Z. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.09.004 · Cited by 66
HBV Vaccines: Advances and Development
Mahmood, F., Xu, R., Awan, M. U. N., Song, Y., Han, Q., Xia, X., Jia, W. P., Xu, J., Peng, J., & Zhang, J. (2023) · Vaccines · doi:10.3390/vaccines11121862 · Cited by 76
Novel Vaccination Protocol with Two Live Mucosal Vectors Elicits Strong Cell-Mediated Immunity in the Vagina and Protects against Vaginal Virus Challenge
Li, Z., Zhang, M., Zhou, C., Zhao, X., Iijima, N., & Frankel, F. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2504 · Cited by 65
Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
Ohno, S., Kohyama, S., Taneichi, M., Moriya, O., Hayashi, H., Oda, H., Mori, M., Kobayashi, A., Akatsuka, T., Uchida, T., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.001 · Cited by 65
Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus–adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN
Adams, W. C. T., Bond, E., Havenga, M. J. E., Holterman, L., Goudsmit, J., Hedestam, G. B. K., Koup, R. A., & Loré, K. (2009) · Journal of General Virology · doi:10.1099/vir.0.008342-0 · Cited by 65
Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses
Chmielewska, A., Naddeo, M., Capone, S., Ammendola, V., Hu, K., Meredith, L. W., Verhoye, L., Rychłowska, M., Rappuoli, R., Ulmer, J. B., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03574-13 · Cited by 65
Genetic Manipulation of Human Embryonic Stem Cells: A System to Study Early Human Development and Potential Therapeutic Applications
Menéndez, P. R., Wang, L., & Bhatia, M. (2005) · Current Gene Therapy · doi:10.2174/1566523054546198 · Cited by 64
Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?
Saso, A., & Kampmann, B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00119-5 · Cited by 63
New Rabies Vaccines for Use in Humans
Ertl, H. C. J. (2019) · Vaccines · doi:10.3390/vaccines7020054 · Cited by 63
Self-citation
Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use
Vasireddy, D., Atluri, P., Malayala, S. V., Vanaparthy, R., & Mohan, G. (2021) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4490 · Cited by 64
Single-Dose Protection againstPlasmodium bergheiby a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A
Sridhar, S., Reyes‐Sandoval, A., Draper, S. J., Moore, A., Gilbert, S. C., Gao, G., Wilson, J. M., & Hill, A. V. S. (2008) · Journal of Virology · doi:10.1128/jvi.02568-07 · Cited by 63
Therapeutic Angiogenesis by Transplantation of Human Embryonic Stem Cell-Derived CD133 + Endothelial Progenitor Cells for Cardiac Repair
Rufaihah, A. J., Haider, H. K., Heng, B. C., Ye, L., Tan, R., Toh, W. S., Tian, X. F., Sim, E. K. W., & Cao, T. (2010) · Regenerative Medicine · doi:10.2217/rme.09.83 · Cited by 61
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
Bilušić, M., McMahon, S., Madan, R. A., Karzai, F. H., Tsai, Y.-T., Donahue, R. N., Palena, C., Jochéms, C., Marté, J. L., Floudas, C. S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002374 · Cited by 60
The recent outbreak of acute severe hepatitis in children of unknown origin – what is known so far
Mücke, M. M., & Zeuzem, S. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.001 · Cited by 60
Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
Kohlmann, R., Schwannecke, S., Tippler, B. G., Ternette, N., Temchura, V., Tenbusch, M., Überla, K., & Grünwald, T. (2009) · Journal of Virology · doi:10.1128/jvi.01036-09 · Cited by 59
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
Stylianou, E., Paul, M. J., Reljić, R., & McShane, H. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1692657 · Cited by 59
Infectious Bronchitis Virus (Gammacoronavirus) in Poultry Farming: Vaccination, Immune Response and Measures for Mitigation
Bhuiyan, M. S. A., Amin, Z., Rodrigues, K. F., Saallah, S., Shaarani, S. M., Sarker, S., & Siddiquee, S. (2021) · Veterinary Sciences · doi:10.3390/vetsci8110273 · Cited by 65
Vector-based genetically modified vaccines: Exploiting Jenner’s legacy
Ramezanpour, B., Haan, I., Osterhaus, A. D. M. E., & Claassen, E. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.06.059 · Cited by 58
Enhanced and Sustained CD8+ T Cell Responses with an Adenoviral Vector-Based Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain
Mikkelsen, M., Holst, P. J., Bukh, J., Thomsen, A. R., & Christensen, J. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001877 · Cited by 58
Ever closer to a prophylactic vaccine for HCV
Swadling, L., Klenerman, P., & Barnes, E. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.791277 · Cited by 57
Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28
Kahl, C. A., Bonnell, J. C., Hiriyanna, S., Fultz, M., Nyberg-Hoffman, C., Chen, P., King, C. R., & Gall, J. G. D. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.050 · Cited by 57
Adenovirus purification by two-column, size-exclusion, simulated countercurrent chromatography
Nestola, P., Silva, R. J. S., Peixoto, C., Alves, P. M., Carrondo, M. J. T., & Mota, J. P. B. (2014) · Journal of Chromatography A · doi:10.1016/j.chroma.2014.04.079 · Cited by 57
Directing endothelial differentiation of human embryonic stem cells via transduction with an adenoviral vector expressing the VEGF165 gene
Rufaihah, A. J., Haider, H. K., Heng, B. C., Ye, L., Toh, W. S., Tian, X. F., Lü, K., Sim, E. K. W., & Cao, T. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1034 · Cited by 57
A Review on the Stability Challenges of Advanced Biologic Therapeutics
Sarvepalli, S., Pasika, S. R., Verma, V., Thumma, A., Bolla, S., Nukala, P. K., Butreddy, A., & Bolla, P. K. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050550 · Cited by 63
The Th1 Immune Response toPlasmodium falciparumCircumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
Radošević, K., Rodrı́guez, A., Lemckert, A. A. C., van der Meer, M., Gillissen, G. F., Warnar, C., von Eyben, R., Pau, M. G., & Goudsmit, J. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00311-10 · Cited by 56
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
Balint, J. P., Gabitzsch, E. S., Rice, A., Latchman, Y. E., Xu, Y., Messerschmidt, G. L., Chaudhry, A., Morse, M. A., & Jones, F. R. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1706-4 · Cited by 57
Innate Immune Response to Adenovirus
Nazir, S. A., & Metcalf, J. P. (2005) · Journal of Investigative Medicine · doi:10.2310/6650.2005.53605 · Cited by 56
Type I IFN Signaling on Both B and CD4 T Cells Is Required for Protective Antibody Response to Adenovirus
Zhu, J., Huang, X., & Yang, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3505 · Cited by 55
Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice
Shiratsuchi, T., Rai, U., Krause, A., Worgall, S., & Tsuji, M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39812 · Cited by 55
Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
Lou, F., Li, M., Pang, Z., Jiang, L., Guan, L., Tian, L., Hu, J., Fan, J., & Fan, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.744242 · Cited by 54
Quality of the Transgene-Specific CD8+ T Cell Response Induced by Adenoviral Vector Immunization Is Critically Influenced by Virus Dose and Route of Vaccination
Holst, P. J., Ørskov, C., Thomsen, A. R., & Christensen, J. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900537 · Cited by 54
A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis
Wang, C., Dulal, P., Zhou, X., Xiang, Z., Goharriz, H., Banyard, A. C., Green, N., Brunner, L., Ventura, R., Collin, N., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006870 · Cited by 56
Self-citation
Ebola virus disease candidate vaccines under evaluation in clinical trials
Martins, K. A. O., Jahrling, P. B., Bavari, S., & Kuhn, J. H. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1187566 · Cited by 53
Model of the Trimeric Fiber and Its Interactions with the Pentameric Penton Base of Human Adenovirus by Cryo-electron Microscopy
Liu, H., Wu, L., & Zhou, Z. H. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.11.043 · Cited by 53
A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever
Sun, Y., Li, H., Tian, D., Han, Q.-Y., Zhang, X., Li, N., & Qiu, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.085 · Cited by 53
Adenovirus-Based Genetic Vaccines for Biodefense
Boyer, J. L., Kobinger, G., Wilson, J. M., & Crystal, R. G. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.157 · Cited by 53
Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells
Lotfi, M., Rad, D. M., Mashhadi, S., Ashouri, A., Mojarrad, M., Mozaffari‐Jovin, S., Farrokhi, S., Hashemi, M., Lotfi, M., Warkiani, M. E., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10585-3 · Cited by 54
Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity
Osada, T., Yang, X. Y., Hartman, Z. C., Glass, O., Hodges, B. L., Niedzwiecki, D., Morse, M. A., Lyerly, H. K., Amalfitano, A., & Clay, T. M. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.17 · Cited by 52
Prime–boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu +metastatic breast cancer in mice
Wang, X., Wang, J., Rao, X., Price, J. E., Zhou, H. S., & Lachman, L. B. (2005) · Breast Cancer Research · doi:10.1186/bcr1199 · Cited by 52
Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut
Lin, S., Cun, A., Harris-McCoy, K., & Ertl, H. C. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.044 · Cited by 51
Self-citation
A Novel Recombinant Peste des Petits Ruminants-Canine Adenovirus Vaccine Elicits Long-Lasting Neutralizing Antibody Response against PPR in Goats
Qin, J., Huang, H., Ruan, Y., Hou, X., Yang, S., Wang, C., Huang, G., Wang, T., Feng, N., Gao, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037170 · Cited by 51
Protective Immunity against Respiratory Tract Challenge withYersinia pestisin Mice Immunized with an Adenovirus‐Based Vaccine Vector Expressing V Antigen
Chiuchiolo, M. J., Boyer, J. L., Krause, A., Senina, S., Hackett, N. R., & Crystal, R. G. (2006) · The Journal of Infectious Diseases · doi:10.1086/507644 · Cited by 50
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
Santra, S., Sun, Y., Korioth-Schmitz, B., Fitzgerald, J. C., Charbonneau, C., Santos, G., Seaman, M. S., Ratcliffe, S. J., Montefiori, D. C., Nabel, G. J., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.050 · Cited by 50
Self-citation
Evaluation of Adenovirus Vectors Containing Serotype 35 Fibers for Vaccination
Paolo, N. C. D., Ni, S., Gaggar, A., Strauss, R., Tuve, S., Li, Z. Y., Stone, D., Shayakhmetov, D. M., Kiviat, N., Touré, P. S., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.12.008 · Cited by 50
Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application
Cordeiro, A. S., Patil‐Sen, Y., Shivkumar, M., Patel, R., Khedr, A., & Elsawy, M. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122091 · Cited by 54
Vault Nanoparticles Containing an Adenovirus-Derived Membrane Lytic Protein Facilitate Toxin and Gene Transfer
Lai, C., Wiethoff, C. M., Kickhoefer, V. A., Rome, L. H., & Nemerow, G. R. (2009) · ACS Nano · doi:10.1021/nn8008504 · Cited by 49
Current concepts and progress in RSV vaccine development
Guvenel, A., Chiu, C., & Openshaw, P. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.878653 · Cited by 49
Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice
Bliss, C. M., Parsons, A. J., Nachbagauer, R., Hamilton, J. R., Cappuccini, F., Ulaszewska, M., Webber, J. P., Clayton, A., Hill, A. V. S., & Coughlan, L. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.12.003 · Cited by 52
Memory CD4 T cells enhance primary CD8 T-cell responses
Krawczyk, C. M., Shen, H., & Pearce, E. J. (2007) · Infection and Immunity · doi:10.1128/iai.00086-07 · Cited by 48
Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4+T-Cell Responses and Confers Enhanced Protection
Bayer, W., Tenbusch, M., Lietz, R., Johrden, L., Schimmer, S., Überla, K., Dittmer, U., & Wildner, O. (2009) · Journal of Virology · doi:10.1128/jvi.01840-09 · Cited by 48
Active Immunotherapy Combined With Blockade of a Coinhibitory Pathway Achieves Regression of Large Tumor Masses in Cancer-prone Mice
Lasaro, M. O., Sazanovich, M., Giles‐Davis, W., Mrass, P., Bunte, R. M., Sewell, D. A., Hussain, S. F., Fu, Y., Weninger, W., Paterson, Y. Y. W., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.88 · Cited by 49
Self-citation
Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
Vitelli, A., Folgori, A., Scarselli, E., Colloca, S., Capone, S., & Nicosia, A. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1394842 · Cited by 49
Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model
Sharma, A., Bangari, D. S., Tandon, M., Pandey, A., HogenEsch, H., & Mittal, S. K. (2009) · Virology · doi:10.1016/j.virol.2009.01.008 · Cited by 48
Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
Harro, C. D., Sun, X., Stek, J. E., Leavitt, R. Y., Mehrotra, D. V., Wang, F., Bett, A. J., Casimiro, D. R., Shiver, J. W., DiNubile, M. J., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00144-09 · Cited by 48
Viral vectors in malaria vaccine development
Limbach, K. J., & Richie, T. L. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01141.x · Cited by 47
Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector
Zhang, Q., Su, X., Seto, D., Zheng, B., Tian, X., Sheng, H., Li, H., Wang, Y., & Zhou, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.039 · Cited by 47
Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity
Sanchez, S., Palacio, N. M., Dangi, T., Ciucci, T., & Penaloza‐MacMaster, P. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi8635 · Cited by 43
Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes
Fattori, E., Zampaglione, I., Arcuri, M., Meola, A., Ercole, B. B., Cirillo, A., Folgori, A., Bett, A. J., Cappelletti, M., Sporeno, E., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302754 · Cited by 47
COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review
Mahroum, N., Lavine, N., Ohayon, A., Seida, R., Alwani, A., Alrais, M., Zoubi, M., & Bragazzi, N. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.872683 · Cited by 50
Viruses—from pathogens to vaccine carriers
Small, J. C., & Ertl, H. C. J. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.07.009 · Cited by 45
Self-citation
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development
Jayawardena, N., Burga, L. N., Poirier, J. T., & Bostina, M. (2019) · Oncolytic Virotherapy · doi:10.2147/ov.s218494 · Cited by 45
Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice
Guo, L., Wang, J., Zhou, H., Si, H., Wang, M., Song, J., Han, B., Shu, Y., Ren, L., Qu, J., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.039 · Cited by 45
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
Folegatti, P. M., Jenkin, D., Morris, S. J., Gilbert, S. C., Kim, D., Robertson, J. S., Smith, E. R., Martin, E., Gurwith, M., & Chen, R. T. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.008 · Cited by 44
Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review
Garg, I., Sheikh, A. B., Pal, S., & Shekhar, R. (2022) · Infectious Disease Reports · doi:10.3390/idr14040057 · Cited by 47
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer
Yan, J., Kang, D. D., Turnbull, G., & Dong, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114042 · Cited by 45
Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Aβ1‐6 upregulates IL‐10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease
Kim, H., Tahara, K., Maxwell, J. A., Lalonde, R., Fukuiwa, T., Fujihashi, K., Kampen, K. R. V., Kong, F.-K., Tang, D.-C. C., & Fukuchi, K. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.993 · Cited by 43
Integrated Single-Cell Atlases Reveal an Oral SARS-CoV-2 Infection and Transmission AxisPreprint
Huang, N., Pérez, P., Kato, T., Mikami, Y., Okuda, K., Gilmore, R. C., Conde, C. D., Gasmi, B., Stein, S. R., Beach, M. E., et al. (2020) · medRxiv · doi:10.1101/2020.10.26.20219089 · Cited by 44
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
Bullard, B. L., Corder, B. N., Gorman, M. J., Diamond, M., & Weaver, E. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-35755-z · Cited by 47
New therapeutic vaccination strategies for the treatment of chronic hepatitis B
Liu, J., Kosinska, A. D., Lu, M., & Roggendorf, M. (2014) · Virologica Sinica · doi:10.1007/s12250-014-3410-5 · Cited by 42
Vaccines targeting drugs of abuse: is the glass half-empty or half-full?
Janda, K. D., & Treweek, J. B. (2011) · Nature reviews. Immunology · doi:10.1038/nri3130 · Cited by 42
Progress in the development of vaccines for hepatitis C virus infection
Ghasemi, F. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i42.11984 · Cited by 45
Suppression of Peritoneal Tumorigenesis by Placenta-Derived Mesenchymal Stem Cells Expressing Endostatin on Colorectal Cancer
Zhang, D., Zheng, L., Shi, H., Chen, X., Wan, Y., Zhang, H., Li, M., Lu, L., Luo, S., Yin, T., et al. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.8758 · Cited by 41
Vaccine design: emerging concepts and renewed optimism
Grimm, S. K., & Ackerman, M. E. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.015 · Cited by 41
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
Chiaro, J., Kasanen, H. H. E., Whalley, T., Capasso, C., Grönholm, M., Feola, S., Peltonen, K., Hamdan, F., Hernberg, M., Mäkelä, S., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0814 · Cited by 40
A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
Bliss, C. M., Freyn, A. W., Caniels, T. G., Leyva-Grado, V. H., Nachbagauer, R., Sun, W., Tan, G. S., Gillespie, V., McMahon, M., Krammer, F., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.011 · Cited by 40
On the Role of CD4+ T Cells in the CD8+ T-Cell Response Elicited by Recombinant Adenovirus Vaccines
Yang, T. C., Millar, J., Groves, T., Zhou, W., Grinshtein, N., Parsons, R., Evelegh, C. M., Xing, Z., Wan, Y., & Bramson, J. L. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300130 · Cited by 41
Current Use of Adenovirus Vectors and Their Production Methods
Sayedahmed, E. E., KUMARI, R. R., & Mittal, S. K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9065-8_9 · Cited by 39
SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040793 · Cited by 43
Serotype Specificity of Adenovirus Purification Using Anion-Exchange Chromatography
Konz, J., Livingood, R. C., Bett, A. J., Goerke, A. R., Laska, M. E., & Sagar, S. L. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1346 · Cited by 39
Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease
Hadas, Y., Katz, M. G., Bridges, C. R., & Zangi, L. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1367 · Cited by 37
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
Elkashif, A., Alhashimi, M., Sayedahmed, E. E., Sambhara, S. R., & Mittal, S. K. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1345 · Cited by 41
Microneedle arrays integrated with living organisms for smart biomedical applications
Cai, B., Gong, Y., Wang, Z., Wang, L., & Chen, W. (2021) · Theranostics · doi:10.7150/thno.66478 · Cited by 37
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
Lai, R., Afkhami, S., Haddadi, S., Jeyanathan, M., & Xing, Z. (2015) · European Respiratory Review · doi:10.1183/16000617.00002515 · Cited by 38
An adenoviral vector-based mucosal vaccine is effective in protection against botulism
Xu, Q., Pichichero, M. E., Simpson, L. L., Elias, M., Smith, L. A., & Zeng, M. (2009) · Gene Therapy · doi:10.1038/gt.2008.181 · Cited by 38
An Antidote for Acute Cocaine Toxicity
Treweek, J. B., & Janda, K. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200588v · Cited by 38
The effects of radial shock waves on gene transfer in rabbit chondrocytes in vitro
Murata, R., Nakagawa, K., Ohtori, S., Ochiai, N., Arai, M., Saisu, T., Sasho, T., Takahashi, K., & Moriya, H. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.04.001 · Cited by 38
Transposon-Assisted Cloning and Traceless Mutagenesis of Adenoviruses: Development of a Novel Vector Based on SpeciesD
Ruzsics, Z., Wagner, M., Osterlehner, A., Cook, J., Koszinowski, U. H., & Burgert, H.-G. (2006) · Journal of Virology · doi:10.1128/jvi.00687-06 · Cited by 38
Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector
Oka, K., Belalcazar, L. M., Dieker, C., Nour, E. A., Nuno-Gonzalez, P., Paul, A., Cormier, S., Shin, J.-K., Finegold, M. J., & Chan, L. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302819 · Cited by 38
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys
Rodrı́guez, A., Mintardjo, R., Tax, D., Gillissen, G. F., Custers, J. H. H. V., Pau, M. G., Klap, J. M., Santra, S., Balachandran, H., Letvin, N. L., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.106 · Cited by 38

Authors: Tatsis, N., & Ertl, H. C. J.
Affiliations: The Wistar Institute (US)
Corresponding author: Ertl, Hildegund C.J.
ORCID: Ertl, Hildegund C.J.
Venue: Molecular Therapy
Publisher: Elsevier BV
Published: 2004-10
Volume: 10
Issue: 4
Pages: 616-629
ISSN: 1525-0016 (ISSN-L)
DOI: 10.1016/j.ymthe.2004.07.013
PMC: PMC7106330
OpenAlex: W1972258033
Cited by: 669
References: 134
Citations by year: 2026: 16 · 2025: 28 · 2024: 31 · 2023: 60 · 2022: 58 · 2021: 69 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 24 · 2014: 21 · 2013: 28 · 2012: 23
FWCI: 3.15
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4389 d)
Locations: Molecular Therapy (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords: adenoviral vector, vaccine vectors, subunit vaccine, viral vaccines, innate immune response, adaptive immune response, transgene expression, HIV-1 vaccine, malaria vaccine, tumor-associated antigens
MeSH terms: Adenoviridae, Adenoviridae Infections, Genes, Viral, Genetic Vectors, Humans, Peptides, Viral Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adenoviruses as vaccine vectors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks